CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale SENIOR VICE PRESIDENT, R&D sold 2,437 shares at $19.46 ($47,424)
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 10,736 shares at $19.46 ($208,923)
- 4 Planned sale SVP, GC & CORPORATE SECRETARY sold 2,437 shares at $19.46 ($47,424)
- 4 Planned sale Director sold 16,000 shares at $20.00 ($320,000)
- 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 1,584 shares at $18.94 ($30,002)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 865 shares at $18.94 ($16,384)
- 4 Open-market sale SVP, CHIEF ACCOUNTING OFFICER sold 925 shares at $18.94 ($17,520)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- 4 Planned sale CHIEF MEDICAL OFFICER sold 2,506 shares at an average $19.04 ($47,715)
- 4 Planned sale SVP, CHIEF ACCOUNTING OFFICER sold 15,000 shares at $17.22 ($258,278)
Page 15 of 65 · 1,286 filings